Questcor falls as Citron says FTC investigation looms

|By:, SA News Editor

Questcor Pharmaceuticals (QCOR -1.9%) slides hard after Citron Research says the FTC is investigating the company's acquisition of Synacthen, a synthetic version of the active ingredient in Acthar.

Full report is here